Neoadjuvant or Adjuvant Epirubicin, Cyclophosphamide, and Paclitaxel in Treating Women With Stage I, Stage II, or Stage III Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: BIOLOGICAL: filgrastim|DRUG: cyclophosphamide|DRUG: epirubicin hydrochloride|DRUG: paclitaxel|PROCEDURE: adjuvant therapy|PROCEDURE: neoadjuvant therapy
Sponsor: Memorial Sloan Kettering Cancer Center
Collaborators: National Cancer Institute (NCI)|Pharmacia|Amgen